J&J no liability
This article was originally published in The Tan Sheet
Executive Summary
A California jury cleared McNeil Consumer & Specialty Pharmaceuticals on July 17 of liability in a lawsuit filed by 11-year-old Sabrina Brierton Johnson, who suffered Stevens-Johnson syndrome after using Children's Motrin. Johnson, who is now blind, will appeal her case, which alleges the Johnson & Johnson division failed to adequately warn on its product label that the ibuprofen in Motrin can trigger a rare allergic reaction that causes blindness and even death, according to lawyers at Greene Broillet & Wheeler, which represented the girl and her parents in the case litigated in Los Angeles Superior Court ("The Tan Sheet" June 16, 2008, p. 9)...
You may also be interested in...
Children’s Motrin Suit Seeks Compensation, New Label For Ibuprofen Product
A lawsuit that alleges Children's Motrin with ibuprofen caused a girl's blindness wants McNeil Consumer & Specialty Pharmaceuticals to clearly list all potential serious adverse reactions on the product's label and compensate the child
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.